March is Colorectal Cancer Awareness Month, a time to stress the importance of screening and early treatment in improving ...

California Republicans vie to capitalize on their November victories and break Democratic supermajority while balancing Trump ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED", the "Company" or "we") (HKEX: 13; Nasdaq/AIM: HCM) today reports its financial r ...

Retiring in Thailand can be affordable and enjoyable, but many retirees lose money due to common mistakes. High living costs, scams, and unexpected expenses can quickly drain savings. There are five ...

FDA accepts Capricor's Biologics License Application for priority review, advancing deramiocel for DMD cardiomyopathy.

On March 19, the Food and Drug Administration granted traditional approval to pembrolizumab, or Keytruda, marketed by Merck (MRK), with ...

Johnson & Johnson's nipocalimab earns FDA Fast Track status for Sjögren's disease, speeding development and review for unmet medical needs.

CAMBRIDGE, Mass. – Korro Bio, Inc. (NASDAQ:KRRO), a clinical-stage biopharmaceutical company with a market capitalization of $231 million, has received orphan drug designation from the U.S. Food ...

The FDA’s ODD program supports the development of treatments for rare diseases that affect fewer than 200,000 people in the U.S. Benefits of the designation include tax credits, FDA application ...

Alexion Pharmaceuticals’ ravulizumab for the prevention of delayed graft function after renal transplantation was granted FDA orphan ...

Kelly Price looks at a new regulatory status and how Oncology Brands are using it to their advantage. The FDA's new Breakthrough Therapy designation may offer oncology brands a powerful way ...

The drug is the only candidate to receive FDA breakthrough designation in the condition, and was granted the status based on phase 2 trial data from patients with IgA nephropathy and other kidney ...